Assists in identifying the immunosuppressant responsible for a specific adverse effect in transplant patients
Provides guidance in distinguishing the cutaneous adverse effects of antiviral agents from effects directly due to HIV disease
Identifies cutaneous manifestations of primary immunodeficiencies
Proposes appropriate treatment strategies